Renal transplantation in systemic vasculitis: When is it safe

Nephrology Dialysis Transplantation

Volumn 24, Issue 10, 2009, Pages 3219-3225

  Little, Mark A ^a   Hassan, Basma ^a   Jacques, Steve ^a   Game, David ^b   Salisbury, Emma ^b   Courtney, Aisling E ^c   Brown, Catherine ^d   Salama, Alan D ^b   Harper, Lorraine ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

^d BEAUMONT HOSPITAL   (Ireland)

Author keywords

ANCA; Survey; Transplantation; Vasculitis; Vasculopathy

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; RECIPIENT; REMISSION; SYSTEMIC VASCULITIS; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349512249     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp347     Document Type: Article

References (28)

1. Little MA, Nazar L, Farrington K. Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidity. Nephrol Dial Transplant 2004; 19: 356-364
2. Booth AD, Almond MK, Burns A et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41: 776-784
3. Slot MC, Tervaert JW, Franssen CF et al. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 2003; 63: 670-677
4. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 1998; 9: 1258-1263
5. Schmitt W,Opelz G, Van Der Woude F. Renal transplantation (RTx) is safe and successful in Wegener's granulomatosis (WG): data from the Collaborative Transplant Study. J Am Soc Nephrol 2002; 13: 564A-565A
6. Briggs JD, JonesE.Renal transplantation for uncommon diseases. Scientific Advisory Board of the ERA-EDTA Registry. European Renal
7. Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999; 14: 570-575
8. Elmedhem A, Adu D, Savage CO. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant 2003; 18: 1001-1004
9. Moroni G, Torri A, Gallelli B et al. The long-term prognosis of renal transplant in patients with systemic vasculitis. Am J Transplant 2007; 7: 2133-2139
10. Briganti EM, Russ GR, McNeil JJ et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347: 103-109
11. Nachman PH, Segelmark M, Westman K et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 1999; 56: 1544-1550
12. Jonker M, Danskine A, Haanstra K et al. The autoimmune response to vimentin after renal transplantation in nonhuman primates is im-munosuppression dependent. Transplantation 2005; 80: 385-393
13. Azimzadeh AM, Pfeiffer S, Wu GS et al. Humoral immunity to vi-mentin is associated with cardiac allograft injury in nonhuman primates. Am J Transplant 2005; 5: 2349-2359
14. Jurcevic S, Ainsworth ME, Pomerance A et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001; 71: 886-892
15. Sato S, Kitamura H, Adachi A et al. Reduplicated basal lamina of the peritubular capillaries in renal biopsy specimens. J Submicrosc Cytol Pathol 2005; 37: 305-311
16. Merkel PA, Cuthbertson DD, Hellmich B et al. Comparison of disease activity measures for anti-neutrophil cytoplasmic autoanti-body (ANCA)-associated vasculitis. Ann Rheum Dis 2009; 68: 103-106
17. Schmitt WH, Haubitz M, Mistry N et al. Renal transplantation in Wegener's granulomatosis. Lancet 1993; 342: 860
18. Haubitz M, Kliem V, Koch KM et al.Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients. Transplantation 1997; 63: 1251-1257 (Pubitemid 27212818)
19. Netzer KO, Merkel F, Weber M. Goodpasture syndrome and end-stage renal failure-to transplant or not to transplant? Nephrol Dial Transplant 1998; 13: 1346-1348
20. Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc Nephrol 1999; 10: 2446-2453
21. Yehia M, Matheson PJ, Merrilees MJ et al. Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques. Nephrology (Carlton) 2006; 11: 261-266
22. Vasilescu ER, Ho EK, de la Torre L et al. Anti-HLA antibodies in heart transplantation. Transpl Immunol 2004; 12: 177-183
23. Rose EA, Pepino P, Barr ML et al. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant 1992; 11(3 Pt 2): S120-S123
24. Sun Q, Liu Z, Chen J et al. Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection. Clin J Am Soc Nephrol 2008; 3: 1479-1486
25. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-1056
26. Sebastian JK, Mahr AD, Ahmed SS et al. Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations. J Rheumatol 2007; 34: 1027-1031
27. Bordron A, Dueymes M, Levy Y et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998; 101: 2029-2035
28. Lu X, Garfield A, Rainger GE et al. Mediation of endothelial cell damagebyserine proteases,but not superoxide, released from antineu-trophil cytoplasmic antibody-stimulated neutrophils. Arthritis Rheum 2006; 54: 1619-1628